Onderneming Revolution Medicines, Inc.
Aandelen
RVMD
US76155X1000
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
35,71 USD | +1,08% | +1,92% | +24,09% |
12/04 | REVOLUTION MEDICINES, INC. : Oppenheimer herhaalt koopadvies | ZM |
12/04 | REVOLUTION MEDICINES, INC. : Needham & Co. ontvangt een koopadvies | ZM |
Vakgebied
Aantal werknemers: 378
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Targeted Therapies
100,0
%
| 35 | 100,0 % | 12 | 100,0 % | -67,27% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 35 | 100,0 % | 12 | 100,0 % | -67,27% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 01-10-14 |
Jack Anders
DFI | Director of Finance/CFO | 47 | 01-08-18 |
Wally Reiher
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-15 |
Wei Lin
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-04-23 |
Steve Kelsey
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-03-17 |
Peg Horn
COO | Chief Operating Officer | 61 | - |
Linnet Zia
PRN | Corporate Officer/Principal | - | 01-03-19 |
Jeff Cislini
LAW | General Counsel | 49 | 01-01-20 |
Daniel Simon
PRN | Corporate Officer/Principal | - | 01-09-22 |
Luan M. Wilfong
HRO | Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 01-10-14 |
Alexis Borisy
BRD | Director/Board Member | 52 | 01-11-14 |
Sandra Horning
BRD | Director/Board Member | 75 | 09/11 |
Barbara Weber
BRD | Director/Board Member | 67 | 01-04-18 |
Thilo Schroeder
BRD | Director/Board Member | 42 | 01-03-18 |
Lorence Kim
BRD | Director/Board Member | 49 | 12-07-22 |
Director/Board Member | 66 | 01-03-15 | |
Flavia Borellini
BRD | Director/Board Member | 65 | 22-06-21 |
Sushil Patel
BRD | Director/Board Member | 53 | 16-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 170 250 408 | 159 826 812 ( 93,88 %) | 5 560 000 ( 3,266 %) | 93,88 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,09% | 5,82 mld. | |
+1,62% | 42,59 mld. | |
+7,83% | 40,65 mld. | |
+48,54% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+8,29% | 24,81 mld. | |
-24,16% | 18,17 mld. | |
+28,65% | 12,05 mld. | |
-2,93% | 11,7 mld. | |
+7,36% | 11,1 mld. |
- Beurs
- Aandelen
- Koers RVMD
- Onderneming Revolution Medicines, Inc.